-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$34.7573.23% Upside
Jasper Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Jasper Therapeutics, Inc.?
Jasper Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, Evercore ISI, Cantor Fitzgerald, Credit Suisse in the past 90 days.